The University of Chicago Header Logo

Connection

Takemasa Tsuji to CD40 Ligand

Back to Details
This is a "connection" page, showing publications Takemasa Tsuji has written about CD40 Ligand.
Takemasa Tsuji
Connection Strength
0.116
CD40 Ligand
  1. Effect of Montanide and poly-ICLC adjuvant on human self/tumor antigen-specific CD4+ T cells in phase I overlapping long peptide vaccine trial. Cancer Immunol Res. 2013 Nov; 1(5):340-50.
    View in: PubMed
    Score: 0.116
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.